Cassava Sciences (SAVA) News Today → 8,788% Return Predicted For THIS Crypto (already up 40% in 6 months) (From Paradigm Press) (Ad) Free SAVA Stock Alerts $21.28 -0.01 (-0.05%) (As of 03/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSAVA Apr 2024 20.500 putca.finance.yahoo.com - March 18 at 4:24 AMROSEN, A LEADING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVAstockhouse.com - March 17 at 6:23 PMCassava Sciences: Where Did All The Mild Alzheimer's Disease Patients Go?seekingalpha.com - March 17 at 1:23 PMSAVA Mar 2024 19.500 putfinance.yahoo.com - March 16 at 10:24 AMSAVA Mar 2024 11.000 putfinance.yahoo.com - March 15 at 11:07 AMSAVA Mar 2024 17.500 callfinance.yahoo.com - March 14 at 10:10 PMUPCOMING SAVA DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Cassava Sciences, Inc. Investors to Lead the Class Action Lawsuit!stockhouse.com - March 14 at 7:09 AMSAVA Jan 2025 2.500 callfinance.yahoo.com - March 12 at 11:31 PMONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassavamarkets.businessinsider.com - March 12 at 11:05 PMSAVA Aug 2024 12.500 callfinance.yahoo.com - March 12 at 6:04 PMCassava Sciences (NASDAQ:SAVA) Trading Up 7%marketbeat.com - March 12 at 1:24 PMBoeing, Oracle, Meta Platforms, Cassava Sciences, Tesla: 5 Stocks Capturing Investors’ Attention Todaymsn.com - March 12 at 7:47 AMAlzheimer's Drug Trial Results Questioned After 'Damning' FDA Inspection Reportbenzinga.com - March 12 at 2:07 AMDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava Sciencesmarkets.businessinsider.com - March 11 at 9:07 PMCassava Sciences again under scrutiny over Alzheimer's drug researchmsn.com - March 11 at 9:07 PMROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVAprnewswire.com - March 11 at 5:10 PMSAVA Apr 2024 17.500 callfinance.yahoo.com - March 11 at 3:22 PMCassava is money spinner – Minister, Nnajimsn.com - March 11 at 10:22 AMSAVA Mar 2024 17.000 callfinance.yahoo.com - March 10 at 9:55 PMSAVA Mar 2024 22.000 callfinance.yahoo.com - March 10 at 11:54 AMSAVA Mar 2024 20.500 putca.finance.yahoo.com - March 8 at 10:43 PMEquities Analysts Offer Predictions for Cassava Sciences, Inc.'s FY2024 Earnings (NASDAQ:SAVA)americanbankingnews.com - March 8 at 2:24 AMCassava Sciences, Inc. to Post FY2024 Earnings of ($2.01) Per Share, HC Wainwright Forecasts (NASDAQ:SAVA)marketbeat.com - March 7 at 7:23 AMSAVA Mar 2024 21.500 calluk.finance.yahoo.com - March 7 at 12:09 AMCassava Sciences Announces Virtual Presentation at the AD/PD(TM) 2024 International Conferencestockhouse.com - March 6 at 7:09 PMBullish Cassava Sciences Insiders Loaded Up On US$3.12m Of Stockfinance.yahoo.com - March 6 at 7:09 PMHC Wainwright Weighs in on Cassava Sciences, Inc.'s Q1 2024 Earnings (NASDAQ:SAVA)marketbeat.com - March 6 at 7:31 AMSAVA SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Cassava Sciences, Inc. Investors to Lead the Class Action Lawsuit!stockhouse.com - March 5 at 10:06 AMCassava Sciences (NASDAQ:SAVA) Stock Rating Reaffirmed by HC Wainwrightmarketbeat.com - March 5 at 8:18 AMROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVAprnewswire.com - March 4 at 3:00 PMCassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International Conferencefinance.yahoo.com - March 4 at 9:19 AMCassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International Conferenceglobenewswire.com - March 4 at 9:15 AMSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVAprnewswire.com - March 3 at 10:10 AMSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassavaprnewswire.com - February 29 at 10:45 AMAnalysts Are Bullish on These Healthcare Stocks: Cassava Sciences (SAVA), Repare Therapeutics (RPTX)markets.businessinsider.com - February 28 at 9:30 PMCassava Sciences Inc (SAVA) Reports Full-Year 2023 Financial Resultsfinance.yahoo.com - February 28 at 10:56 AMCassava Sciences Reports Full-year 2023 Financial Results and Corporate Updatesglobenewswire.com - February 28 at 9:14 AMCassava Deadline Reminderstockhouse.com - February 27 at 6:24 PMSAVA Apr 2024 21.000 putfinance.yahoo.com - February 25 at 10:43 PMSAVA Mar 2024 19.500 callfinance.yahoo.com - February 25 at 5:42 PMSAVA Aug 2024 15.000 putfinance.yahoo.com - February 24 at 2:17 PMROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVAprnewswire.com - February 24 at 10:00 AMSAVA Mar 2024 24.000 putfinance.yahoo.com - February 24 at 8:47 AMPotential gene targets for managing cassava whitefly, a viral diseases vector threatening food securitymsn.com - February 23 at 8:36 AMCassava Sciences Investor Deadline Approachingmarkets.businessinsider.com - February 22 at 12:17 PMThe women, poems and menus saving Ecuador's beloved blue crabbbc.com - February 22 at 7:17 AMExit Now! 3 Biotech Stocks to Sell in February 2024investorplace.com - February 21 at 4:50 PMCASSAVA SCIENCES INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Cassava Sciences To Contact Him Directly To Discuss Their Optionsprnewswire.com - February 21 at 10:45 AMWhat is backward and uncompetitive? Our institutionsmsn.com - February 20 at 2:41 PMSAVA Feb 2024 32.000 callfinance.yahoo.com - February 17 at 1:35 PM Get Cassava Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SAVA and its competitors with MarketBeat's FREE daily newsletter. Email Address The only AI company you should be looking at (Ad)This is the ONLY AI company you should be watching right now. No. It's not Nvidia, Intel, or Microsoft... It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human. This new drug discovery technique will change the market. And that's why they received a $50 million investment from an AI powerhouse. Get the stock ticker here >>> SAVA Media Mentions By Week SAVA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SAVA News Sentiment▼0.250.64▲Average Medical News Sentiment SAVA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SAVA Articles This Week▼134▲SAVA Articles Average Week Get Cassava Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SAVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Liquidia News Today Pliant Therapeutics News Today Innoviva News Today ABIVAX Société Anonyme News Today ORIC Pharmaceuticals News Today Arcutis Biotherapeutics News Today Evolus News Today Wave Life Sciences News Today Tyra Biosciences News Today ARS Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SAVA) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThe world’s greatest investmentPorter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingBill Gates Bets on $15 Trillion BonanzaWeiss RatingsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cassava Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.